SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Eagle Pharmaceuticals, inc. (EGRX)

EGRX RSS Feed
Add EGRX Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board:
Last Post: 9/21/2016 9:41:17 AM - Followers: 30 - Board type: Free - Posts Today: 0
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
EGRX
Current Price
Volume:
Bid Ask Day's Range
SureTrader
EGRX News: Amended Statement of Beneficial Ownership (sc 13d/a) 09/23/2016 05:18:07 PM
EGRX News: Statement of Changes in Beneficial Ownership (4) 09/23/2016 05:17:17 PM
EGRX News: Securities Registration: Employee Benefit Plan (s-8) 09/16/2016 04:47:36 PM
EGRX News: Current Report Filing (8-k) 09/13/2016 08:09:22 AM
EGRX News: Statement of Changes in Beneficial Ownership (4) 09/08/2016 05:03:33 PM
PostSubject
#499  Sticky Note Eagle Pharmaceuticals, Inc. Reports Second Quarter 2016 Results Bickema 08/09/16 08:30:08 AM
#519   Notes From Management Meetings - RBC Bickema 09/21/16 09:41:17 AM
#518   So am I confusing averages with highs? Bickema 09/13/16 10:33:38 AM
#517   This is the first reported period where Bendeka's DewDiligence 09/13/16 10:28:03 AM
#516   We been at 80% for a while now Bickema 09/13/16 10:22:29 AM
#515   The ^SPSIBI index of small/midcap biotechs is down DewDiligence 09/13/16 10:17:12 AM
#514   Looks like the only change is in Treanda Double_Bagel 09/13/16 10:15:24 AM
#513   EGRX new corporate slide set: DewDiligence 09/13/16 09:36:07 AM
#512   Is Eagle buying shares on the open market? Bickema 08/29/16 01:36:31 PM
#511   Nice Call, I wasn't sure what the S&P600 Bickema 08/23/16 10:18:00 AM
#510   S&P Effect (type of) jsmith77 08/23/16 08:16:54 AM
#509   Eagle added to S&P SmallCap 600: biotech2020 08/22/16 09:26:23 PM
#508   Hudson Executive more than doubles their stake in Bickema 08/15/16 07:25:29 PM
#507   EGRX new corporate slide set: DewDiligence 08/10/16 09:44:55 AM
#506   The 2Q16 10-Q has been filed: DewDiligence 08/09/16 06:07:30 PM
#505   Also: CEO's termination of 10b5-1 plan, which was DewDiligence 08/09/16 10:47:42 AM
#504   Good to see EGRX getting back to where jsmith77 08/09/16 10:41:12 AM
#503   Brief comments on the 2Q16 results: #msg-124400547. DewDiligence 08/09/16 08:55:44 AM
#502   Could they have included some milestone payments? jsmith77 08/09/16 08:49:46 AM
#501   Looks like I was a little low on DewDiligence 08/09/16 08:40:05 AM
#500   Ryanodex EHS news is very bullish: #msg-124400378. DewDiligence 08/09/16 08:36:38 AM
#499   Eagle Pharmaceuticals, Inc. Reports Second Quarter 2016 Results Bickema 08/09/16 08:30:08 AM
#498   The biggest takeaway from ER is that 'Ryanodex biotech2020 08/09/16 08:25:07 AM
#497   EGRX romanov5 08/09/16 08:21:18 AM
#496   Short Interest.... jsmith77 08/09/16 08:06:24 AM
#495   EGRX romanov5 08/09/16 07:44:58 AM
#494   It should pop up nicely because there is jsmith77 08/09/16 07:32:41 AM
#493   EGRX beats by 9 cents, beats on Revenues romanov5 08/09/16 07:19:15 AM
#492   I am thinking that this might actually happen jsmith77 08/08/16 12:24:38 PM
#491   Teva Pharm eyes more acquisitions after buying Allergan's Bickema 08/08/16 11:29:59 AM
#490   Also Eagle could be expecting some additional milestone jsmith77 08/04/16 09:04:54 AM
#489   2Q16 Bendeka royalty was approximately $24M: #msg-124305562. DewDiligence 08/04/16 08:37:21 AM
#488   Teva reports Q2 EPS $1.25, consensus $1.20 Double_Bagel 08/04/16 07:32:19 AM
#487   No need to apologize, it is very unclear Bickema 07/28/16 07:54:28 PM
#486   What it means for EGRX is unclear. DewDiligence 07/28/16 10:09:59 AM
#485   I am sorry to be obtuse, but what Double_Bagel 07/28/16 10:07:15 AM
#484   Ok thanks for that info. I wonder if Bickema 07/27/16 11:27:00 AM
#483   Other than the authorized generic Sandoz sells with DewDiligence 07/27/16 11:10:17 AM
#482   Interesting comment for a drug who's peak sales Bickema 07/27/16 10:47:36 AM
#481   In addition to what I tweeted (https://twitter.com/DewDiligence/status/758293180 DewDiligence 07/27/16 10:34:30 AM
#480   Dew I saw your tweet about possible angiomax Bickema 07/27/16 10:13:30 AM
#479   That's news to me. I don't see how DewDiligence 07/14/16 03:28:54 PM
#478   Thanks for the color. I should have just Bickema 07/14/16 03:23:53 PM
#477   The ordinary generic versions of Angiomax infringe MDCO's DewDiligence 07/14/16 03:18:41 PM
#476   I was referring to Angiomax generics and not Bickema 07/14/16 03:12:40 PM
#475   Kangio does not infringe any of MDCO's remaining DewDiligence 07/14/16 02:52:19 PM
#474   So now that the patents have been ruled Bickema 07/14/16 02:49:13 PM
#473   Annual Report letter to shareholders: DewDiligence 07/12/16 05:29:12 PM
#472   Angiomax addendum: MDCO would gain nothing by suing DewDiligence 07/11/16 04:50:34 PM
#471   So, yes—this is a lucrative market opportunity for Bickema 07/11/16 04:41:40 PM
#469   Angiomax is protected by two Orange Book patents DewDiligence 07/11/16 04:26:02 PM
PostSubject